Insider Transactions Reported by 25 Insiders of C4 Therapeutics, Inc.

Symbol
CCCC on Nasdaq
Location
Watertown, MA

Insiders trading volume in the past year

C4 Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
MARC A. COHEN Director $12,879,484 22 Jun 2022
ALAIN J. COHEN Director $11,770,243 04 Apr 2022
Glenn Dubin Director $6,582,725 01 Apr 2024
Elena Prokupets Director $3,486,942 27 Sep 2021
Andrew Hirsch President & CEO, Director $1,540,201 14 Feb 2025
Stewart Fisher Chief Scientific Officer $921,946 16 Sep 2024
Kenneth Carl Anderson Director $814,522 02 Jan 2026
Kendra Adams Chief Financial Officer $602,395 18 Sep 2025
Kelly Schick Chief People Officer $409,674 13 Feb 2025
Jolie Siegel Chief Legal Officer $406,666 13 Feb 2025
Scott N. Boyle Chief Business Officer $403,006 -$3,651 -0.9% 13 Feb 2025
LEONARD REYNO Chief Medical Officer $347,168 -$22,200 -6% 16 Jan 2026
Lauren White Chief Financial Officer $318,053 30 Aug 2023
Paige Mahaney Chief Scientific Officer $256,338 28 Oct 2025
Adam Crystal Chief Medical Officer $250,282 30 Jan 2023
DONNA ROY GROGAN Director $127,654 02 Jan 2026
Mark Mossler Chief Accounting Officer $57,889 14 Feb 2025
Stephen Fawell Director 18 Jun 2025
Ronald Harold Wilfred Cooper Director 18 Jun 2025
Utpal Koppikar Director 18 Jun 2025
BRUCE DOWNEY Director 20 Jun 2024
Laura Bessen Director 18 Jun 2025
Steven L. Hoerter Director 18 Jun 2025
Owen Hughes Director 18 Jun 2025
Malcolm Salter Director 20 Jun 2024

Recent Insider Transactions by Companies or Individuals for C4 Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.